Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 340articles · 30d
- 2+ hour agolatest article
- Aug 17, 2026earliest in window
- 91%with images
- 291avg words
- Economy, Business & Finance 195
- Health & Wellness 159
- Medical 158
- Business & Industrial 142
- Finance & Business 132
- Health 75
- Science & Technology 53
- Science & Nature 34
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
10+ min ago (544+ words) BioSpace Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation The Initiative Will Make Available 100,000 Disease-Specific Whole Genome Sequences Paired with Longitudinal Clinical Outcomes, with a Long-Term Goal of Reaching 1 Million Genomes CHICAGO--(BUSINESS…...
Incyte Announces Funding of MINJUVI® (tafasitamab) for patients with Relapsed or Refractory Follicular Lymphoma through Ontario's FAST Program
2+ day, 23+ hour ago (346+ words) Despite advances in care, most patients with FL eventually experience relapse, highlighting the need for additional treatment options across multiple lines of therapy.3 The acceptance of cancer therapies such as MINJUVI® in the treatment of FL represents a significant step,…...
Olympus Announces New Class of iTind™ Center of Excellence Program Physicians
3+ day, 11+ min ago (457+ words) Program Aims to Advance Minimally Invasive Treatment of Enlarged Prostate CENTER VALLEY, Pa., Sept. 10, 2026 /PRNewswire/ -- Olympus Corp. of the Americas (Olympus) is pleased to announce the newest members of the iTind™ Center of Excellence (COE) Program, which is designed to…...
AINN-P1: Small Model, Big Intelligence
3+ day, 9+ hour ago (222+ words) Ainnocence Inc., an AI-driven drug discovery company, announced new results for AINN-P1, a purpose-built protein foundation model designed to deliver efficient and transferable predictions for protein engineering and biologics discovery. Transformer all-to-all attention (left) requires n² connections; mLSTM recurrent state passing…...
One Biosciences Receives €3,3 Million Funding Under i-Démo 5 From France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration With Institut Curie
3+ day, 13+ hour ago (265+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...
From process to intelligence: How AI is reshaping people strategy in life sciences
3+ day, 19+ hour ago (401+ words) BioSpace Applying artificial intelligence and automation tactics has played a large role in talent strategy conversations in the past few years While many organizations initially focused on experimenting with tools and driving adoption to create efficiencies, leading employers are now…...
Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer
3+ day, 22+ hour ago (276+ words) Key data that will be presented include: Selected Guardant Health and collaborator presentations at WCLC 2026 Impact of Common Resistance Mechanisms on Real-World Overall Survival (rwOS) for Patients Receiving Osimertinib ctDNA Longitudinal Risk Stratification in NSCLC Using Multiple MRD Platforms in…...
CDR-Life Announces CDR209, a Novel T Cell Engager for Treatment of Axial Spondyloarthritis
4+ day, 12+ hour ago (629+ words) BioSpace CDR-Life Announces CDR209, a Novel T Cell Engager for Treatment of Axial Spondyloarthritis Novel M-gager® candidate designed to selectively target TRBV9-positive autoreactive T cells while preserving normal immune function, with potential applicability across HLA-B27-associated autoimmune diseases ZURICH, Switzerland--(BUSINESS…...
Schr??dinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs
4+ day, 16+ hour ago (545+ words) Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs BioSpace Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology…...
Beren Therapeutics Launches ‘Test for NPC’ to Help Identify People with Niemann-Pick Disease, Type C Who Remain Undiagnosed
4+ day, 12+ hour ago (286+ words) According to the NPC Registry, it takes 2.5-4.3 years after a child’s first neurological symptom to diagnose them with I-NPC. Due to the progressive nature of the disease, early diagnosis is critical to enabling families and healthcare professionals to make earlier…...